Ergobyte was founded in 2002 as a typical software development house, meaning custom projects, design, coding and sales, all handled in its premises. From the beginning, Ergobyte strived to diversify by investing in cutting edge technologies in order to benefit its clients.
Over the years, the company grew in numbers, but also went through some strategic and organisational changes that shaped its future. Months of coding, testing and audience feedback, resulted in Asclepius, a hospital information system developed specifically for the needs of small and medium sized clinics in Greece.
This is how our eHealth journey started. Since 2007 we develop and commercialise software solutions that empower health professionals by assisting them with clinical and pharmaceutical information at the point of care.
Our portfolio of commercial products consists of:
- Galen - Online drug database
- Galen Office - Medical practice management software
- Asclepius - Hospital information system
Being an outward-looking company, Ergobyte gives importance to research and development. Its vision is to foster eHealth innovation in order to support decision making, lower costs and increase automation. Ergobyte has coordinated nationally funded projects and participated in a number of European Commision supported projects.
Success does not just happen. It comes about because a team of dedicated experts share a clear vision and work to bring it together.
Within Ergobyte, development is carried out by a team of skilled software engineers, as assisted by project managers, analysts, designers and science associates. They are all aware of the potential risks and pitfalls in software design and development and, more importantly, how to avoid them. A common software base is used across all products, thus achieving significantly smaller development time and cost while boosting at the same time quality and functionality.
Our team consists of people who are overflowing with enthusiasm. We want them to be fully involved and proud of what they do. Together we are creating a first-class company, by being dedicated to a common cause.